event,time
Here is the table of events and timestamps:,
83 years old ,0.0
male ,0.0
admitted to the hospital ,0.0
fell to the ground ,-24.0
syncope ,-24.0
sepsis ,-24.0
acute prostatitis ,-24.0
leg ecchymosis ,-24.0
anuric ,-24.0
rhabdomyolysis ,-24.0
increased levels of urea ,-24.0
increased levels of creatinine ,-24.0
increased levels of myoglobin ,-24.0
increased levels of CPK ,-24.0
increased levels of LDH ,-24.0
increased levels of CRP ,-24.0
increased levels of PCT ,-24.0
increased levels of total bilirubin ,-24.0
increased levels of direct bilirubin ,-24.0
increased levels of AST ,-24.0
increased levels of ALT ,-24.0
increased levels of PSA ,-24.0
increased levels of white blood cell count ,-24.0
increased levels of neutrophils ,-24.0
blood pressure 105/75 mm Hg ,-24.0
heart rate 110 bpm ,-24.0
body temperature 37.4°C ,-24.0
abdomen ultrasound ,-24.0
no hydronephrosis ,-24.0
empty bladder ,-24.0
traces of blood in bladder catheter ,-24.0
previous renal impairment ,-672.0
prostatic hypertrophy ,-672.0
overactive bladder ,-672.0
recurrent prostatitis ,-672.0
statins not recorded ,-672.0
volume expansion ,-24.0
diuretic treatment ,-24.0
furosemide 125 mg IV ,-24.0
alpha-agonist ,-24.0
antibiotic treatment ,-24.0
femoral central venous catheter placement ,-24.0
HFR-Supra treatment ,-24.0
extracorporeal treatment ,-24.0
myoglobin removal ,-24.0
inflammatory status reduction ,-24.0
fluid balance maintenance ,-24.0
96 h of high-dose furosemide ,-24.0
24-h urine output 300 mL ,-24.0
furosemide tapered to 50 mg/day ,-168.0
oral administration ,-168.0
antibiotic therapy switched to meropenem ,-168.0
blood cultures showed growth of E. coli ,-168.0
resistant to piperacillin/tazobactam ,-168.0
5 HFR-Supra sessions ,-168.0
significant reduction in myoglobin levels ,-168.0
significant reduction in CPK levels ,-168.0
significant reduction in LDH levels ,-168.0
significant reduction in CRP levels ,-168.0
significant reduction in PCT levels ,-168.0
HFR-Supra carried out with 250 mL/min of blood flow ,-168.0
endogenous ultrafiltrate flow 14 L ,-168.0
ultrafiltration rate settled according to clinical status ,-168.0
low molecular weight heparin administered ,-168.0
femoral hemodialysis catheter removed ,-168.0
right jugular central venous catheter placed ,-168.0
dialysis therapy prolonged ,-168.0
3 sessions of on-line hemodiafiltration ,-168.0
2 sessions of high-flux hemodialysis ,-168.0
dialysis no longer required ,-168.0
"urine output 2,300 mL/day ",-168.0
serum levels of urea dropped to 96 mg/dL ,-168.0
serum levels of creatinine dropped to 3.06 mg/dL ,-168.0
serum levels of CRP dropped to 3.2 mg/dL ,-168.0
serum levels of total bilirubin dropped to 0.81 mg/dL ,-168.0
serum levels of AST dropped to 27 IU/L ,-168.0
serum levels of ALT dropped to 25 IU/L ,-168.0
serum levels of PSA dropped to 61 ng/mL ,-168.0
"white blood cell count dropped to 6,300 cells/µL ",-168.0
total hospitalization length 21 days ,-168.0
urea 89 mg/dL ,-504.0
creatinine 2.41 mg/dL ,-504.0
GFR (CKD-EPI) 24 mL/min ,-504.0
